These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9181018)

  • 21. [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
    Mubiayi N; Coutty N; Detourmignies L; Le Goueff F; Decocq J; Delahousse G
    Presse Med; 2004 Aug; 33(14 Pt 1):930-3. PubMed ID: 15509046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.
    Boudaouara Y; Aoun K; Maatoug R; Souissi O; Bouratbine A; Abdallah RB
    Am J Trop Med Hyg; 2018 Jun; 98(6):1722-1726. PubMed ID: 29663900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
    Gratzl R; Hayde M; Kohlhauser C; Hermon M; Burda G; Strobl W; Pollak A
    Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):853-8. PubMed ID: 10052549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis of congenital toxoplasmosis.
    Foulon W; Naessens A; Mahler T; de Waele M; de Catte L; de Meuter F
    Obstet Gynecol; 1990 Nov; 76(5 Pt 1):769-72. PubMed ID: 2216222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
    Mirlesse V; Jacquemard F; Daffos F
    Presse Med; 1993 Feb; 22(6):258-62. PubMed ID: 8511144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of congenital toxoplasmosis.
    Wilson CB
    Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
    [No Abstract]   [Full Text] [Related]  

  • 27. [The Spanish Society of Pediatric Infectious Diseases Guidelines for the diagnosis and treatment of congenital toxoplasmosis].
    Baquero-Artigao F; del Castillo Martín F; Fuentes Corripio I; Goncé Mellgren A; Fortuny Guasch C; de la Calle Fernández-Miranda M; González-Tomé MI; Couceiro Gianzo JA; Neth O; Ramos Amador JT;
    An Pediatr (Barc); 2013 Aug; 79(2):116.e1-116.e16. PubMed ID: 23352717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxoplasma infections in early pregnancy: consequences and management].
    Wallon M; Gaucherand P; Al Kurdi M; Peyron F
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choroidal neovascularization secondary to congenital toxoplasmosis in an infant.
    Mavrikakis E; Levin AV; Lam WC
    Can J Ophthalmol; 2010 Dec; 45(6):e11-2. PubMed ID: 21179180
    [No Abstract]   [Full Text] [Related]  

  • 31. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cotrimoxazole for prenatal treatment of congenital toxoplasmosis?
    Derouin F; Jacqz-Aigrain E; Thulliez P; Couvreur J; Leport C
    Parasitol Today; 2000 Jun; 16(6):254-6. PubMed ID: 10827434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
    Mitchell CD; Erlich SS; Mastrucci MT; Hutto SC; Parks WP; Scott GB
    Pediatr Infect Dis J; 1990 Jul; 9(7):512-8. PubMed ID: 2371084
    [No Abstract]   [Full Text] [Related]  

  • 34. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
    Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
    Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcome of children with congenital toxoplasmosis.
    Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
    Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
    Petersen E; Schmidt DR
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

  • 40. [Congenital toxoplasmosis: randomised comparison of strategies for retinochoroiditis prevention].
    Wallon M; Kieffer F; Binquet C; Thulliez P; Garcia-Méric P; Dureau P; Franck J; Peyron F; Bonnin A; Villena I; Bonithon-Kopp C; Gouyon JB; Masson S; Félin A; Cornu C
    Therapie; 2011; 66(6):473-80. PubMed ID: 22186072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.